Karen Kelly
Pediatrics · Clearwater, FLNPI 1508842790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $470 and has fallen 57.2% since, to $201 in 2025. Among pediatrics clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $20.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$266
- Tris Pharma Inc$240
- Pfizer$227
- Corium, LLC$197
- Merck$196
- Supernus Pharmaceuticals, Inc.$166
- plus $616 from 12 others
Across 24 payments — averaging $90,314 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Diasorin Molecular LLC$2.1M
- GSK$37K
- Sanofi Pasteur Inc.$19K
- Modernatx, Inc.$8K
- Lumos Diagnostics, Inc.$2K
What the payments were for
- Food & beverage$1,908100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $266 |
| Tris Pharma Inc | 10 | $240 |
| Pfizer | 14 | $227 |
| Corium, LLC | 10 | $197 |
| Merck | 10 | $196 |
| Supernus Pharmaceuticals, Inc. | 4 | $166 |
| Cranial Technologies, Inc | 6 | $115 |
| Adlon Therapeutics L.p. | 6 | $113 |
| Sanofi Pasteur Inc. | 5 | $92 |
| Kaleo, Inc. | 5 | $76 |
| Alk-abello, Inc | 2 | $46 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| Genentech USA, Inc. | 2 | $32 |
| GSK | 2 | $29 |
| AstraZeneca | 1 | $23 |
| Shire North American Group Inc | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$119
- Dyanavel XR$112
How this compares
$1,908 in reported general payments places this provider in the 90th percentile of 3,964 pediatrics providers in Florida.
Other pediatrics in Clearwater
- Jorge Lujan-ZilbermanTampa$378K
- Bonnie SmeryageHollywood$153K
- Patricia DeanMiami$92K
- Ryan CantvilleJacksonville$87K
- Christina CanodyTampa$87K
- Sofia MirandaMiami$67K
- Jose HerreraMiami$61K
- Joanna DavisMiami$59K
- Anastasia Albanese-O'neillGainesville$42K
- Monica ShahBrandon$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.